Targeting leukocyte metabolism to treat human autoimmune disease

Information

• Research Project
• 9694797

• ApplicationId

  9694797

• Core Project Number

  R44AI138725

• Full Project Number

  4R44AI138725-02

• Serial Number

  138725

• FOA Number

  PA-17-302

• Sub Project Id

• Project Start Date

  3/1/2018 - 7 years ago

• Project End Date

  7/31/2021 - 4 years ago

• Program Officer Name

  MINNICOZZI, MICHAEL

• Budget Start Date

  8/15/2018 - 7 years ago

• Budget End Date

  7/31/2019 - 6 years ago

• Fiscal Year

  2018

• Support Year

  02

• Suffix

• Award Notice Date

  8/14/2018 - 7 years ago

Organizations

• IMMUNEXT, INC.

IC Name

• Activity

  R44

• Administering IC

  AI

• Application Type

  4

• Direct Cost Amount

• Indirect Cost Amount

• Total Cost

  995802

• Sub Project Total Cost

• ARRA Funded

  False

• CFDA Code

  855

• Ed Inst. Type

• Funding ICs

  NIAID:995802\

• Funding Mechanism

  SBIR-STTR RPGs

• Study Section

  ZRG1

• Study Section Name

  Special Emphasis Panel

• Organization Name

  IMMUNEXT, INC.

• Organization Department

• Organization DUNS

  967719241

• Organization City

  LEBANON

• Organization State

  NH

• Organization Country

  UNITED STATES

• Organization Zip Code

  037561000

• Organization District

  UNITED STATES